Search research articles
Contact Us
Filters
Showing results (101-110 of 332) with videos related to
Page
of 34
Sort By:
International Journal of Molecular Sciences
|
May 13, 2026
Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin
Sophie Helfenstein, Inna Shaforostova, Katja Seipel, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
RNA Targeting in Acute Myeloid Leukemia
Alessandra Messikommer, Katja Seipel, Stephen Byrne, et al.
Blood
|
April 8, 2011
Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML
Simon Haefliger, Christiane Klebig, Kerstin Schaubitzer, et al.
Journal of Clinical Medicine
|
September 23, 2022
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study
Christian Rausch, Ulrike Bacher, Manuela Rabaglio, et al.
Cancers
|
February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
Ekaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Cancers
|
April 13, 2023
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma
Fabrizio Huwyler, Rebekka Kunz, Ulrike Bacher, et al.
Hematological Oncology
|
October 21, 2025
Randomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma
Christian Rausch, Ulrike Bacher, Manuela Rabaglio, et al.
Leukemia & Lymphoma
|
October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)
Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Leukemia Research
|
June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential
Isabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Blood Reviews
|
May 6, 2018
Current status and trends in the diagnostics of AML and MDS
Evgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 332) with videos related to
Sort By:
Page
of 34
International Journal of Molecular Sciences
|
May 13, 2026
Analysis of Clinical Impact of CD33 rs12459419 Single-Nucleotide Polymorphism in AML Treated with Intensive Chemotherapy Without Gemtuzumab Ozogamicin
Sophie Helfenstein, Inna Shaforostova, Katja Seipel, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
RNA Targeting in Acute Myeloid Leukemia
Alessandra Messikommer, Katja Seipel, Stephen Byrne, et al.
Blood
|
April 8, 2011
Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML
Simon Haefliger, Christiane Klebig, Kerstin Schaubitzer, et al.
Journal of Clinical Medicine
|
September 23, 2022
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study
Christian Rausch, Ulrike Bacher, Manuela Rabaglio, et al.
Cancers
|
February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
Ekaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Cancers
|
April 13, 2023
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma
Fabrizio Huwyler, Rebekka Kunz, Ulrike Bacher, et al.
Hematological Oncology
|
October 21, 2025
Randomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma
Christian Rausch, Ulrike Bacher, Manuela Rabaglio, et al.
Leukemia & Lymphoma
|
October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)
Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Leukemia Research
|
June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential
Isabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Blood Reviews
|
May 6, 2018
Current status and trends in the diagnostics of AML and MDS
Evgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Page
of 34